How should gastric burning that occurs during intravenous iron infusion be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Gastric Burning During IV Iron Infusion

Slow or temporarily stop the infusion immediately, as gastric burning represents a mild infusion reaction that typically resolves with rate reduction or brief interruption. 1

Understanding the Symptom

Gastric burning during IV iron infusion is classified as a mild infusion reaction, most commonly representing complement activation-related pseudo-allergy (CARPA, also known as a Fishbane reaction) rather than true anaphylaxis. 1 True anaphylaxis to IV iron is exceedingly rare, occurring in less than 1:200,000 administrations. 1

Immediate Management Algorithm

Step 1: Rate Modification

  • Immediately slow the infusion rate or pause it temporarily
  • Most mild reactions, including gastric burning, resolve within minutes of rate reduction
  • Once symptoms resolve, the infusion can typically be resumed at a slower rate

Step 2: Symptom Assessment

Monitor for progression to more serious symptoms:

  • Chest tightness or difficulty breathing
  • Hypotension or tachycardia
  • Urticaria or angioedema
  • Severe abdominal pain (beyond burning sensation)

If symptoms remain isolated to gastric burning without progression, continue with slower infusion rate.

Step 3: Documentation

  • Document the reaction type, severity, and management
  • Note the specific iron formulation used
  • Record the infusion rate at which symptoms occurred

Rechallenge Considerations

Rechallenge with the same IV iron formulation may be attempted following this mild infusion reaction. 1 However, evidence suggests:

  • If rechallenge is needed, consider switching to a different iron formulation rather than using the same one, as this significantly reduces reaction rates (5-21% with alternate formulation vs 32-68% with same formulation). 2
  • If the same formulation must be used, administer at a slower rate from the start
  • Routine premedication is NOT recommended unless the patient is at high risk for hypersensitivity reactions (multiple drug allergies, severe atopy, previous severe reaction). 1

Important Caveats

Avoid Routine Premedication

The 2024 expert consensus guidelines explicitly state that premedication should be reserved only for high-risk patients. 1 Paradoxically, patients who receive premedication have a 23-fold higher incidence of adverse events (38.6% vs 1.7%), likely because premedication is given to those already at higher risk. 2

Formulation Selection Matters

If recurrent mild reactions occur:

  • Optimal formulations for total dose infusion (TDI): ferumoxytol, low molecular weight iron dextran (LMWID), ferric derisomaltose (FDI) 1
  • These formulations have lower reaction rates: ferumoxytol (1.8%), ferric carboxymaltose (1.4%) compared to iron sucrose (4.3%) 2

Not a Contraindication

Gastric burning alone does not represent a contraindication to future IV iron therapy. The symptom is manageable with rate adjustment and does not predict severe reactions.

Distinguish from Gastric Ulceration

While extremely rare, chronic frequent IV iron administration (biweekly infusions) combined with frequent blood transfusions has been associated with iron-induced gastric ulceration and bleeding. 3 However, this is a chronic complication of repeated therapy, not an acute infusion reaction. Isolated gastric burning during a single infusion does not suggest this pathology.

Post-Infusion Monitoring

Routine 30-minute post-infusion monitoring is NOT indicated per current guidelines. 1 Most infusion reactions occur during the infusion itself, not afterward.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.